Mutations in BSCL2, which encodes the protein seipin, and AGPAT2, which encodes lysophosphatidic acid acyltransferase B, lead to biochemical disruptions such as hypertriglyceridemia, hypoadiponectemia, and hyperglycemia [4,5]. Here, BSCL2 is linked to hypertriglyceridemia.